{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:37:02Z","timestamp":1771562222634,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T00:00:00Z","timestamp":1346889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1038\/bjc.2012.380","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T22:55:39Z","timestamp":1346972139000},"page":"1423-1432","source":"Crossref","is-referenced-by-count":21,"title":["The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma"],"prefix":"10.1038","volume":"107","author":[{"given":"E","family":"Hatzimichael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Lo Nigro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Lattanzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Dasoula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Janczar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Vivenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Monteverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Merlano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Papoudou-Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Stebbing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J S","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L E","family":"Karran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"ElguetaKarstegl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Crook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,6]]},"reference":[{"issue":"5","key":"BFbjc2012380_CR1","doi-asserted-by":"publisher","first-page":"e10560","DOI":"10.1371\/journal.pone.0010560","volume":"5","author":"D Baldridge","year":"2010","unstructured":"Baldridge D, Lennington J, Weis M, Homan EP, Jiang MM, Munivez E, Keene DR, Hogue WR, Pyott S, Byers PH, Krakow D, Cohn DH, Eyre DR, Lee B, Morello R (2010) Generalized connective tissue disease in Crtap\u2212\/\u2212 mouse. PloS One 5 (5): e10560","journal-title":"PloS One"},{"issue":"12","key":"BFbjc2012380_CR2","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/humu.20799","volume":"29","author":"D Baldridge","year":"2008","unstructured":"Baldridge D, Schwarze U, Morello R, Lennington J, Bertin TK, Pace JM, Pepin MG, Weis M, Eyre DR, Walsh J, Lambert D, Green A, Robinson H, Michelson M, Houge G, Lindman C, Martin J, Ward J, Lemyre E, Mitchell JJ, Krakow D, Rimoin DL, Cohn DH, Byers PH, Lee B (2008) CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Human Mutation 29 (12): 1435\u20131442","journal-title":"Human Mutation"},{"issue":"6","key":"BFbjc2012380_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00428-008-0593-x","volume":"452","author":"MA Belaud-Rotureau","year":"2008","unstructured":"Belaud-Rotureau MA, Marietta V, Vergier B, Mainhaguiet G, Turmo M, Idrissi Y, Ferrer J, Beylot-Barry M, Dubus P, Merlio JP (2008) Inactivation of p16INK4a\/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas. Virchows Archiv Int J Pathol 452 (6): 607\u2013620","journal-title":"Virchows Archiv Int J Pathol"},{"issue":"3","key":"BFbjc2012380_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ng1968","volume":"39","author":"WA Cabral","year":"2007","unstructured":"Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC (2007) Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta. Nat Genet 39 (3): 359\u2013365","journal-title":"Nat Genet"},{"issue":"4","key":"BFbjc2012380_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0037-1963(00)90019-2","volume":"37","author":"RS Chaganti","year":"2000","unstructured":"Chaganti RS, Nanjangud G, Schmidt H, Teruya-Feldstein J (2000) Recurring chromosomal abnormalities in non-Hodgkin\u2019s lymphoma: biologic and clinical significance. Sem Hematol 37 (4): 396\u2013411","journal-title":"Sem Hematol"},{"issue":"4","key":"BFbjc2012380_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.hoc.2009.04.004","volume":"23","author":"L de Leval","year":"2009","unstructured":"de Leval L, Hasserjian RP (2009) Diffuse large B-cell lymphomas and burkitt lymphoma. Hem-oncol Clin N Am 23 (4): 791\u2013827","journal-title":"Hem-oncol Clin N Am"},{"issue":"4","key":"BFbjc2012380_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3324\/haematol.2010.033167","volume":"96","author":"FC Eberle","year":"2011","unstructured":"Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES (2011) Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin\u2019s lymphoma and primary mediastinal large B-cell lymphoma. Haematologica 96 (4): 558\u2013566","journal-title":"Haematologica"},{"issue":"7","key":"BFbjc2012380_CR8","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/S0021-9258(19)41624-4","volume":"250","author":"RM Gryder","year":"1975","unstructured":"Gryder RM, Lamon M, Adams E (1975) Sequence position of 3-hydroxyproline in basement membrane collagen. Isolation of glycyl-3-hydroxyprolyl-4-hydroxyproline from swine kidney. J Biol Chem 250 (7): 2470\u20132474","journal-title":"J Biol Chem"},{"issue":"9","key":"BFbjc2012380_CR9","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1182\/blood-2009-12-256446","volume":"116","author":"H Guan","year":"2010","unstructured":"Guan H, Xie L, Leithauser F, Flossbach L, Moller P, Wirth T, Ushmorov A (2010) KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood 116 (9): 1469\u20131478","journal-title":"Blood"},{"issue":"18","key":"BFbjc2012380_CR10","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1182\/blood-2010-12-322362","volume":"117","author":"G Gutierrez-Garcia","year":"2011","unstructured":"Gutierrez-Garcia G, Cardesa-Salzmann T, Climent F, Gonzalez-Barca E, Mercadal S, Mate JL, Sancho JM, Arenillas L, Serrano S, Escoda L, Martinez S, Valera A, Martinez A, Jares P, Pinyol M, Garcia-Herrera A, Martinez-Trillos A, Gine E, Villamor N, Campo E, Colomo L, Lopez-Guillermo A (2011) Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood 117 (18): 4836\u20134843","journal-title":"Blood"},{"issue":"2","key":"BFbjc2012380_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.bbrc.2004.03.060","volume":"317","author":"S Jarnum","year":"2004","unstructured":"Jarnum S, Kjellman C, Darabi A, Nilsson I, Edvardsen K, Aman P (2004) LEPREL1, a novel ER and Golgi resident member of the Leprecan family. Biochem Biophys Res Commun 317 (2): 342\u2013351","journal-title":"Biochem Biophys Res Commun"},{"issue":"32","key":"BFbjc2012380_CR12","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1038\/sj.onc.1203696","volume":"19","author":"SC Kaul","year":"2000","unstructured":"Kaul SC, Sugihara T, Yoshida A, Nomura H, Wadhwa R (2000) Gros1, a potential growth suppressor on chromosome 1: its identity to basement membrane-associated proteoglycan, leprecan. Oncogene 19 (32): 3576\u20133583","journal-title":"Oncogene"},{"issue":"2","key":"BFbjc2012380_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.bjc.6605711","volume":"103","author":"S Lee","year":"2010","unstructured":"Lee S, Syed N, Taylor J, Smith P, Griffin B, Baens M, Bai M, Bourantas K, Stebbing J, Naresh K, Nelson M, Tuthill M, Bower M, Hatzimichael E, Crook T (2010) DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt\u2019s lymphoma. Br J Cancer 103 (2): 265\u2013274","journal-title":"Br J Cancer"},{"issue":"3","key":"BFbjc2012380_CR14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ajhg.2011.08.003","volume":"89","author":"S Mordechai","year":"2011","unstructured":"Mordechai S, Gradstein L, Pasanen A, Ofir R, El Amour K, Levy J, Belfair N, Lifshitz T, Joshua S, Narkis G, Elbedour K, Myllyharju J, Birk OS (2011) High myopia caused by a mutation in LEPREL1, encoding prolyl 3-hydroxylase 2. Am J Human Genet 89 (3): 438\u2013445","journal-title":"Am J Human Genet"},{"issue":"2","key":"BFbjc2012380_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","volume":"127","author":"R Morello","year":"2006","unstructured":"Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bachinger HP, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B (2006) CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127 (2): 291\u2013304","journal-title":"Cell"},{"issue":"3","key":"BFbjc2012380_CR16","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.2353\/ajpath.2010.100052","volume":"177","author":"PG Murray","year":"2010","unstructured":"Murray PG, Fan Y, Davies G, Ying J, Geng H, Ng KM, Li H, Gao Z, Wei W, Bose S, Anderton J, Kapatai G, Reynolds G, Ito A, Marafioti T, Woodman CB, Ambinder R, Tao Q (2010) Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis. Am J Pathol 177 (3): 1480\u20131490","journal-title":"Am J Pathol"},{"issue":"4","key":"BFbjc2012380_CR17","first-page":"447","volume":"25","author":"ST Ong","year":"1998","unstructured":"Ong ST, Le Beau MM (1998) Chromosomal abnormalities and molecular genetics of non-Hodgkin\u2019s lymphoma. Sem Oncol 25 (4): 447\u2013460","journal-title":"Sem Oncol"},{"issue":"9","key":"BFbjc2012380_CR18","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","volume":"28","author":"R Piva","year":"2010","unstructured":"Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I, Fornari A, Martinoglio B, Medico E, Zamo A, Facchetti F, Ponzoni M, Geissinger E, Rosenwald A, Muller-Hermelink HK, De Wolf-Peeters C, Piccaluga PP, Pileri S, Neri A, Inghirami G (2010) Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 28 (9): 1583\u20131590","journal-title":"J Clin Oncol"},{"issue":"14","key":"BFbjc2012380_CR19","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1200\/JCO.2010.32.8385","volume":"29","author":"I Salaverria","year":"2011","unstructured":"Salaverria I, Siebert R (2011) The gray zone between Burkitt\u2019s lymphoma and diffuse large B-cell lymphoma from a genetics perspective. J Clin Oncol 29 (14): 1835\u20131843","journal-title":"J Clin Oncol"},{"issue":"10","key":"BFbjc2012380_CR20","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/sj.bjc.6605042","volume":"100","author":"R Shah","year":"2009","unstructured":"Shah R, Smith P, Purdie C, Quinlan P, Baker L, Aman P, Thompson AM, Crook T (2009) The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. Br J Cancer 100 (10): 1687\u20131696","journal-title":"Br J Cancer"},{"issue":"1","key":"BFbjc2012380_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1182\/blood-2005-03-1194","volume":"107","author":"N Syed","year":"2006","unstructured":"Syed N, Smith P, Sullivan A, Spender LC, Dyer M, Karran L, O\u2019Nions J, Allday M, Hoffmann I, Crawford D, Griffin B, Farrell PJ, Crook T (2006) Transcriptional silencing of Polo-like kinase 2 (SNK\/PLK2) is a frequent event in B-cell malignancies. Blood 107 (1): 250\u2013256","journal-title":"Blood"},{"issue":"28","key":"BFbjc2012380_CR22","doi-asserted-by":"publisher","first-page":"19432","DOI":"10.1074\/jbc.M802973200","volume":"283","author":"P Tiainen","year":"2008","unstructured":"Tiainen P, Pasanen A, Sormunen R, Myllyharju J (2008) Characterization of recombinant human prolyl 3-hydroxylase isoenzyme 2, an enzyme modifying the basement membrane collagen IV. J Biol Chem 283 (28): 19432\u201319439","journal-title":"J Biol Chem"},{"key":"BFbjc2012380_CR23","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/leu.2012.83","volume":"29","author":"C Visco","year":"2012","unstructured":"Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu WM, Kahl BS, d\u2019Amore ES, Montes-Moreno S, Dybkaer K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O\u2019Neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WW, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJ, Piris MA, Moller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH (2012) Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP consortium program study. Leukemia 29: 2103\u20132113","journal-title":"Leukemia"},{"issue":"22","key":"BFbjc2012380_CR24","doi-asserted-by":"publisher","first-page":"23615","DOI":"10.1074\/jbc.M312807200","volume":"279","author":"JA Vranka","year":"2004","unstructured":"Vranka JA, Sakai LY, Bachinger HP (2004) Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J Biol Chem 279 (22): 23615\u201323621","journal-title":"J Biol Chem"},{"issue":"35","key":"BFbjc2012380_CR25","doi-asserted-by":"publisher","first-page":"25004","DOI":"10.1074\/jbc.274.35.25004","volume":"274","author":"DJ Wassenhove-McCarthy","year":"1999","unstructured":"Wassenhove-McCarthy DJ, McCarthy KJ (1999) Molecular characterization of a novel basement membrane-associated proteoglycan, leprecan. J Biol Chem 274 (35): 25004\u201325017","journal-title":"J Biol Chem"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2012380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012380","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:10:08Z","timestamp":1684415408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2012380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,6]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["BFbjc2012380"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.380","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,6]]}}}